Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Achieve Life Sciences Inc (NQ: ACHV )

6.800 +0.480 (+7.59%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 31, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 244,651
Open 6.370
Bid (Size) 6.210 (1)
Ask (Size) 7.000 (15)
Prev. Close 6.320
Today's Range 5.510 - 6.860
52wk Range 2.000 - 8.125
Shares Outstanding 17,930,362
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Top 5 Health Care Stocks That May Collapse
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies. 
Via Benzinga
Achieve Life Sciences Announces Refresh to Board of Directors
From Achieve Life Sciences
Via Globe NewsWire

Performance

YTD
+168.77%
+168.77%
1 Month
+41.37%
+41.37%
3 Month
+177.55%
+177.55%
6 Month
+106.06%
+106.06%
1 Year
-10.17%
-10.17%

More News

Read More
Achieve Life Sciences Announces Last Subject Last Visit Completed in Phase 3 ORCA-3 Trial of Cytisinicline for Smoking Cessation
From Achieve Life Sciences
Via Globe NewsWire
Achieve Life Sciences Announces Last Subject Last Visit Completed in Phase 2 ORCA-V1 Trial of Cytisinicline for e-Cigarette Cessation
From Achieve Life Sciences
Via Globe NewsWire
Achieve Life Sciences Announces Presentation of the Phase 3 ORCA-2 Trial of Cytisinicline at Society for Research on Nicotine and Tobacco (SRNT) Annual Meeting
From Achieve Life Sciences
Via Globe NewsWire
Achieve Life Sciences to Announce Fourth Quarter and Year-End 2022 Financial Results and Host Conference Call and Webcast on March 16, 2023
From Achieve Life Sciences
Via Globe NewsWire
Achieve Life Sciences Announces Last Subject Dosed in Phase 2 ORCA-V1 Trial of Cytisinicline for e-Cigarette Cessation
From Achieve Life Sciences
Via Globe NewsWire
Achieve Life Sciences Announces Granting of New Hire Inducement Award
From Achieve Life Sciences
Via Globe NewsWire
Achieve Life Sciences's Earnings: A Preview
Via Benzinga
Achieve Life Sciences to Participate at the 2023 SVB Securities Global Biopharma Conference
From Achieve Life Sciences
Via Globe NewsWire
Achieve Life Sciences Announces Granting of New Hire Inducement Award
From Achieve Life Sciences
Via Globe NewsWire
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Achieve Life Sciences Announces Last Subject Dosed in Phase 3 ORCA-3 Trial of Cytisinicline for Smoking Cessation
From Achieve Life Sciences
Via Globe NewsWire
Achieve Life Sciences Announces Patent Granted by USPTO for New Cytisinicline Formulation
From Achieve Life Sciences
Via Globe NewsWire
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Why ObsEva Shares Are Trading Higher By Over 70%; Here Are 21 Stocks Moving Premarket
Via Benzinga
Achieve Life Sciences Announces Private Placement of $18.9 Million
From Achieve Life Sciences
Via Globe NewsWire
Achieve Announces Early Completion of Target Enrollment in Cytisinicline e-Cigarette Cessation Trial
From Achieve Life Sciences
Via Globe NewsWire
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
Achieve Life Sciences to Announce Third Quarter Financial Results and Host Conference Call and Webcast on November 14, 2022
From Achieve Life Sciences
Via Globe NewsWire
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
121 Stocks That Hit Their 52-Week Low
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.